Related Experiment Video
Updated: May 20, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Effect of mild-to-moderate COVID‑19 on the incidence and risk factors for deep vein thrombosis in patients with hip
Haoran Li1, Jian Xing1, Zhe Song1
1Orthopedic Trauma Department, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
Insights
Mild-to-moderate COVID-19 did not significantly increase deep vein thrombosis (DVT) risk in hip fracture patients. Routine DVT prevention is recommended for all hip fracture patients, irrespective of SARS-CoV-2 infection status.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Vascular Medicine
Background:
- Hip fractures are prevalent in the elderly, with a significant proportion occurring in inpatients during the COVID-19 pandemic.
- COVID-19's impact on deep vein thrombosis (DVT) risk is complex, with higher incidence reported in severe cases.
- The specific risk of DVT associated with mild-to-moderate COVID-19 in hip fracture patients remains unclear.
Purpose of the Study:
- To investigate the association between mild-to-moderate COVID-19 and the risk of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery.
- To identify independent risk factors for preoperative DVT in hip fracture patients.
Main Methods:
- Retrospective analysis of adult patients who underwent hip fracture surgery between December 2022 and January 2023.
- Preoperative screening for SARS-CoV-2 infection and Doppler ultrasonography (DUS) for DVT detection.
- Logistic regression analysis to determine risk factors for DVT.
Main Results:
- Out of 98 hip fracture patients, 63 tested positive for SARS-CoV-2. Overall DVT incidence was 37% (40% in COVID-19 positive, 31% in COVID-19 negative).
- Mild-to-moderate COVID-19 was not found to be an independent risk factor for DVT in this cohort.
- Preoperative leukocyte count and platelet-to-lymphocyte ratio (PLR) were identified as independent risk factors for DVT.
Conclusions:
- COVID-19 infection, in its mild-to-moderate form, did not significantly elevate the risk of deep vein thrombosis in patients with hip fractures.
- Standard deep vein thrombosis (DVT) prevention protocols should be consistently applied to all hip fracture patients, regardless of their COVID-19 status.
Purpose:
This retrospective study aimed to investigate the effect of mild-to-moderate COVID-19 on the risk of deep vein thrombosis (DVT) in patients with hip fractures. Hip fractures are common in the elderly, and previous research has shown that they accounted for 58.3% of traumatic fractures in older inpatients during the COVID-19 pandemic in China. Meanwhile, the relationship between COVID-19 and DVT is complex. Some studies have reported that the incidence of DVT in critically ill COVID-19 patients can be as high as 46%, and 20% in those with moderate-to-severe cases. However, the impact of mild-to-moderate COVID-19 on DVT risk in hip fracture patients remains unclear.
Methods:
Adult patients who underwent surgery for hip fractures between December 8, 2022, and January 9, 2023, were included in the study. All patients were tested for SARS-CoV-2 nucleic acid and were assessed for DVT preoperatively using doppler ultrasonography (DUS). Logistic regression was used to identify risk factors for DVT.
Results:
The records of 98 patients with hip fractures, were included in the analysis, of whom 63 were SARS-CoV-2 positive and 35 were SARS-CoV-2 negative. Pre-operative DUS showed that 36/98 patients (37%) had DVT, including 25/63 (40%) patients with COVID-19, and 11/35 (31%) patients without COVID-19. Multivariable logistic regression analysis showed that pre-operative leukocyte count and platelet-to-lymphocyte ratio (PLR) were independent risk factors for DVT, whereas mild-to-moderate COVID-19 was not an independent risk factor for DVT. In patients with hip fractures, COVID-19 did not significantly increase the risk of DVT.
Conclusions:
Therefore, in patients with hip fractures, DVT prevention measures should be implemented routinely, regardless of COVID-19 status.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

